EDGAR Filing Documents for 0001628280-22-018808

Form 424B3 - Prospectus [Rule 424(b)(3)]:

SEC Accession No. 0001628280-22-018808

Filing Date

2022-07-11

Accepted

2022-07-11 16:32:43

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	424B3	pointbiopharma-424b3xposam.htm	424B3	391122
2		back_coverx1a.jpg	GRAPHIC	26852
3		prospectus_coverx1a.jpg	GRAPHIC	20614
	Complete submission text file	0001628280-22-018808.txt		457687

Mailing Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268

Business Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268 (317) 543-9957

POINT Biopharma Global Inc. (Filer) CIK: 0001811764 (see all company filings)

IRS No.: 850800493 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-258325 | Film No.: 221077262
SIC: 2834 Pharmaceutical Preparations